These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 8308031)
1. Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. Posner BI; Faure R; Burgess JW; Bevan AP; Lachance D; Zhang-Sun G; Fantus IG; Ng JB; Hall DA; Lum BS J Biol Chem; 1994 Feb; 269(6):4596-604. PubMed ID: 8308031 [TBL] [Abstract][Full Text] [Related]
2. Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis. Bevan AP; Drake PG; Yale JF; Shaver A; Posner BI Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):49-58. PubMed ID: 8927047 [TBL] [Abstract][Full Text] [Related]
3. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen). Band CJ; Posner BI; Dumas V; Contreres JO Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395 [TBL] [Abstract][Full Text] [Related]
4. Selective activation of the rat hepatic endosomal insulin receptor kinase. Role for the endosome in insulin signaling. Bevan AP; Burgess JW; Drake PG; Shaver A; Bergeron JJ; Posner BI J Biol Chem; 1995 May; 270(18):10784-91. PubMed ID: 7537739 [TBL] [Abstract][Full Text] [Related]
5. Vanadate augments insulin-stimulated insulin receptor kinase activity and prolongs insulin action in rat adipocytes. Evidence for transduction of amplitude of signaling into duration of response. Fantus IG; Ahmad F; Deragon G Diabetes; 1994 Mar; 43(3):375-83. PubMed ID: 7508873 [TBL] [Abstract][Full Text] [Related]
6. In vivo insulin mimetic effects of pV compounds: role for tissue targeting in determining potency. Bevan AP; Burgess JW; Yale JF; Drake PG; Lachance D; Baquiran G; Shaver A; Posner BI Am J Physiol; 1995 Jan; 268(1 Pt 1):E60-6. PubMed ID: 7840184 [TBL] [Abstract][Full Text] [Related]
7. Insulin receptor kinase-associated phosphotyrosine phosphatases in hepatic endosomes: assessing the role of phosphotyrosine phosphatase-1B. Li C; Baquiran G; Gu F; Tremblay ML; Fazel A; Bergeron JJ; Posner BI Endocrinology; 2006 Feb; 147(2):912-8. PubMed ID: 16269466 [TBL] [Abstract][Full Text] [Related]
8. In vivo effects of peroxovanadium compounds in BB rats. Yale JF; Vigeant C; Nardolillo C; Chu Q; Yu JZ; Shaver A; Posner BI Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):181-90. PubMed ID: 8927037 [TBL] [Abstract][Full Text] [Related]
9. Insulin receptor-associated protein tyrosine phosphatase(s): role in insulin action. Drake PG; Posner BI Mol Cell Biochem; 1998 May; 182(1-2):79-89. PubMed ID: 9609117 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of pervanadate stimulation and potentiation of insulin-activated glucose transport in rat adipocytes: dissociation from vanadate effect. Shisheva A; Shechter Y Endocrinology; 1993 Oct; 133(4):1562-8. PubMed ID: 8404595 [TBL] [Abstract][Full Text] [Related]
11. A role for tyrosine phosphorylation in both activation and inhibition of the insulin receptor tyrosine kinase in vivo. Drake PG; Bevan AP; Burgess JW; Bergeron JJ; Posner BI Endocrinology; 1996 Nov; 137(11):4960-8. PubMed ID: 8895369 [TBL] [Abstract][Full Text] [Related]
12. Hypoglycemic effects of peroxovanadium compounds in Sprague-Dawley and diabetic BB rats. Yale JF; Lachance D; Bevan AP; Vigeant C; Shaver A; Posner BI Diabetes; 1995 Nov; 44(11):1274-9. PubMed ID: 7589823 [TBL] [Abstract][Full Text] [Related]
13. Decreased in situ insulin receptor dephosphorylation in hyperglycemia-induced insulin resistance in rat adipocytes. Tang S; Le-Tien H; Goldstein BJ; Shin P; Lai R; Fantus IG Diabetes; 2001 Jan; 50(1):83-90. PubMed ID: 11147799 [TBL] [Abstract][Full Text] [Related]
14. Effects of phosphotyrosine phosphatase inhibition on insulin secretion and intracellular signaling events in rat pancreatic islets. Gogg S; Chen J; Efendic S; Smith U; Ostenson C Biochem Biophys Res Commun; 2001 Feb; 280(4):1161-8. PubMed ID: 11162649 [TBL] [Abstract][Full Text] [Related]
15. Insulin Signalling: The Inside Story. Posner BI Can J Diabetes; 2017 Feb; 41(1):108-113. PubMed ID: 27614806 [TBL] [Abstract][Full Text] [Related]
16. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki rats. Abella A; Marti L; Camps M; Claret M; Fernández-Alvarez J; Gomis R; Gumà A; Viguerie N; Carpéné C; Palacín M; Testar X; Zorzano A Diabetes; 2003 Apr; 52(4):1004-13. PubMed ID: 12663473 [TBL] [Abstract][Full Text] [Related]
17. A peroxovanadium compound induces Xenopus oocyte maturation: inhibition by a neutralizing anti-insulin receptor antibody. Cummings C; Zhu L; Sorisky A; Liu XJ Dev Biol; 1996 May; 175(2):338-46. PubMed ID: 8626037 [TBL] [Abstract][Full Text] [Related]
18. A stable peroxovanadium compound with insulin-like action in human fat cells. Eriksson JW; Lönnroth P; Posner BI; Shaver A; Wesslau C; Smith UP Diabetologia; 1996 Feb; 39(2):235-42. PubMed ID: 8635677 [TBL] [Abstract][Full Text] [Related]
19. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner. Zhang-Sun G; Yang C; Viallet J; Feng G; Bergeron JJ; Posner BI Endocrinology; 1996 Jul; 137(7):2649-58. PubMed ID: 8770882 [TBL] [Abstract][Full Text] [Related]
20. Enhanced sensitivity of insulin-resistant adipocytes to vanadate is associated with oxidative stress and decreased reduction of vanadate (+5) to vanadyl (+4). Lu B; Ennis D; Lai R; Bogdanovic E; Nikolov R; Salamon L; Fantus C; Le-Tien H; Fantus IG J Biol Chem; 2001 Sep; 276(38):35589-98. PubMed ID: 11463798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]